Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 556 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$4.99B
Operating Margin
10.90%
TTM Avg
-12.82%
3Y Avg
-40.85%
5Y Avg
-40.85%
Market Cap
$5.13B
Operating Margin
12.75%
TTM Avg
11.82%
3Y Avg
10.28%
5Y Avg
7.77%
Market Cap
$5.15B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-101.20%
5Y Avg
-276.55%
Market Cap
$4.90B
Operating Margin
-4.25%
TTM Avg
-15.13%
3Y Avg
-64.78%
5Y Avg
-194.20%
Market Cap
$4.80B
Operating Margin
-8739.34%
TTM Avg
-5186.54%
3Y Avg
-3135.16%
5Y Avg
-2237.88%
Market Cap
$5.21B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-174.05%
Market Cap
$4.73B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.35B
Operating Margin
29.60%
TTM Avg
36.63%
3Y Avg
34.40%
5Y Avg
32.73%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Erasca, Inc. (ERAS) | $5.05B | 0.00% | 0.00% | 0.00% | 0.00% |
| BillionToOne, Inc. (BLLN)vs › | $4.99B | 10.90% | -12.82% | -40.85% | -40.85% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.13B | 12.75% | 11.82% | 10.28% | 7.77% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.15B | 0.00% | 0.00% | -101.20% | -276.55% |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.90B | -4.25% | -15.13% | -64.78% | -194.20% |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.80B | -8739.34% | -5186.54% | -3135.16% | -2237.88% |
| Cogent Biosciences, Inc. (COGT)vs › | $5.21B | 0.00% | 0.00% | 0.00% | -174.05% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.73B | 0.00% | 0.00% | 0.00% | 0.00% |
| Doximity, Inc. (DOCS)vs › | $5.35B | 29.60% | 36.63% | 34.40% | 32.73% |
| LifeStance Health Group, Inc. (LFST)vs › | $4.71B | 4.95% | -0.41% | -10.80% | -13.67% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
